A Randomized Double‐Blind Placebo‐Controlled First‐In‐Human Phase 1 Trial of TransCon PTH in Healthy Adults
Author:
Affiliation:
1. Ascendis Pharma, Inc. Palo Alto CA USA
2. Ascendis Pharma A/S Hellerup Denmark
Funder
Ascendis Pharma A/S
Publisher
Wiley
Subject
Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4016
Reference24 articles.
1. Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice
2. Management of Hypoparathyroidism: Summary Statement and Guidelines
3. Epidemiology and Diagnosis of Hypoparathyroidism
4. Mortality in patients with permanent hypoparathyroidism after total thyroidectomy
5. Cardiovascular and renal complications to postsurgical hypoparathyroidism: A Danish nationwide controlled historic follow-up study
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial;Advances in Therapy;2024-04-30
2. Preclinical development of EXT608, an investigational parathyroid hormone derivative with extended half-life for the treatment of hypoparathyroidism;JBMR Plus;2024-04-18
3. The hypocalcemic disorders;Feldman and Pike's Vitamin D;2024
4. New directions in the treatment of hypoparathyroidism;Annales d'Endocrinologie;2023-08
5. The rationale for intermittent administration of PTH in the management of mineral and bone disorder of chronic kidney disease;Journal of Nephrology;2023-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3